Megna Health Announces Submission of Application to the FDA for Emergency Use Authorization of its Rapid COVID-19 IgG & IgM Antibody Test for Prescription Home Use
EXTON, PA, May 24, 2021 – Megna Health, a U.S. manufacturer of Rapid COVID Tests based in Exton, Pennsylvania, announced that it has filed a U.S. Food and Drug Administration (FDA) EUA (Emergency Use Authorization) extension for Prescription Home Use for its Rapid COVID-19 IgG/IgM Antibody Test and is preparing for product launch. The test […]